AUC · k for variable inter-occasion CL [NCA / SHAM]

posted by PharmCat  – Russia, 2021-10-01 00:15 (268 d 03:08 ago) – Posting: # 22609
Views: 1,415

Sounds great. One problem ... I don't think that our regulators will be able to understand this, or there will be a desire and dare to change the foundations. Also, I think NLME modeling can be applied.

Complete thread:

UA Flag
 Admin contact
22,167 posts in 4,645 threads, 1,572 registered users;
online 8 (0 registered, 8 guests [including 3 identified bots]).
Forum time: Sunday 03:23 CEST (Europe/Vienna)

The person interested in success has to learn
to view failure as a healthy, inevitable part
of the process of getting to the top.    Joyce Brothers

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz